术前CT与手术切除的离体磨玻璃结节配准以在活体影像上界定浸润性腺癌的空间范围:一项概念验证研究
本研究纳入6例(年龄75±11岁)术前CT显示磨玻璃结节(大小22.5±5.1 mm)且手术切除标本含显著浸润性腺癌成分(>5 mm)的受试者,将离体组织学切片与术前CT进行三维配准,把浸润性腺癌成分的空间范围映射到活体CT上。结果显示三维重建组织学与CT勾画结节重叠良好(65.9±5.2%),对应解剖标志的三维错位减小(1.97±0.42 mm),且浸润区与原位区的CT衰减值(HU)分布不同。作者认为该融合方法可将二维组织学上的浸润性腺癌成分空间映射到活体CT。
要点
- 离体组织学与术前CT三维配准重叠良好(65.9±5.2%),对应解剖标志三维错位为1.97±0.42 mm。
- 浸润性腺癌区与原位区的CT衰减值(HU)分布不同。
- 该方法可将二维组织学上的浸润性腺癌成分空间映射到活体CT。
核心结论
- 这项概念验证研究提示,该融合方法能够将二维组织学切片上的浸润性腺癌成分空间映射到活体CT上。
研究设计与样本
- 概念验证研究,纳入6例受试者(年龄75±11岁),均有术前CT及手术切除的磨玻璃结节(大小22.5±5.1 mm)且含显著浸润性腺癌成分(>5 mm);由病理学家在数字化组织学标本上勾画病变范围,两名放射科医生和一名肺与危重症医生在CT上勾画整个结节(平面内分辨率<0.8 mm,层间距1-5 mm);采用新重建方法以CT为空间约束在三维中定位组织学切片。
关键影像表现/征象
- 三维重建组织学与CT勾画结节重叠良好(65.9±5.2%)。
- 组织学与CT上对应解剖标志的三维错位减小(1.97±0.42 mm)。
- 浸润区与原位区的CT衰减值(HU)分布不同。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop an approach for radiology-pathology fusion of ex vivo histology of surgically excised pulmonary nodules with pre-operative CT, to radiologically map spatial extent of the invasive adenocarcinomatous component of the nodule.
METHODS: Six subjects (age: 75 ± 11 years) with pre-operative CT and surgically excised ground-glass nodules (size: 22.5 ± 5.1 mm) with a significant invasive adenocarcinomatous component (>5 mm) were included. The pathologist outlined disease extent on digitized histology specimens; two radiologists and a pulmonary critical care physician delineated the entire nodule on CT (in-plane resolution: <0.8 mm, inter-slice distance: 1-5 mm). We introduced a novel reconstruction approach to localize histology slices in 3D relative to each other while using CT scan as spatial constraint. This enabled the spatial mapping of the extent of tumour invasion from histology onto CT.
RESULTS: Good overlap of the 3D reconstructed histology and the nodule outlined on CT was observed (65.9 ± 5.2%). Reduction in 3D misalignment of corresponding anatomical landmarks on histology and CT was observed (1.97 ± 0.42 mm). Moreover, the CT attenuation (HU) distributions were different when comparing invasive and in situ regions.
CONCLUSION: This proof-of-concept study suggests that our fusion method can enable the spatial mapping of the invasive adenocarcinomatous component from 2D histology slices onto in vivo CT.
KEY POINTS: • 3D reconstructions are generated from 2D histology specimens of ground glass nodules. • The reconstruction methodology used pre-operative in vivo CT as 3D spatial constraint. • The methodology maps adenocarcinoma extent from digitized histology onto in vivo CT. • The methodology potentially facilitates the discovery of CT signature of invasive adenocarcinoma.
引用
- Rusu M, Rajiah P, Gilkeson R, et al. Co-registration of pre-operative CT with ex vivo surgically excised ground glass nodules to define spatial extent of invasive adenocarcinoma on in vivo imaging: a proof-of-concept study. Eur Radiol. 2017. PMID: 28386717. doi:10.1007/s00330-017-4813-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。